Pharmaceutical glass manufacturer Stevanato Group will begin construction on a $145 million facility in Fishers, Indiana, USA later this month.
The site is expected to be in operation in 2023 and will enable the company to be closer to its North America pharmaceutical customers and provide an additional supply source for its mission critical products to serve customers better.
Stevanato Group expects to invest approximatively $145million to build and equip the manufacturing facility.
The plant, which is expected to be up to 370,000ft2, will support the expansion and production of Stevanato Group’s EZ-Fill solutions, pre-sterilized drug containment systems for pharmaceutical use.
The facility is expected to house production lines equipped with advanced process technologies to produce EZ-Fill syringes and vials.
Stevanato Group’s EZ-Fill solutions offer benefits to pharmaceutical companies by reducing time to market, lowering the overall total cost of ownership and reducing supply chain risk.
The new facility will also be used as a centre for after-sales support for its North America engineering customers, offering technical support as well as maintenance for visual inspection, assembly and packaging equipment.
Stevanato Group celebrated the new plant with a groundbreaking ceremony in Fishers in late September attended by Indiana Governor Eric J. Holcomb, Fishers Mayor Scott Fadness, and other local guests.
Franco Moro, Stevanato Group Chief Executive Officer, said: “We are thrilled to begin construction on our new US hub, and expand our presence in one of the fastest growing markets where we see increasing demand.
"We believe this will allow us to further enhance our services to our valued North America customers and underscores our desire to ensure supply chain security, just in time delivery and reliable sourcing in terms of surge capacity."
